dihydroergocristine has been researched along with dihydroergocryptine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
| Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
| BERCEL, NA | 1 |
| Bicalho, B; De Nucci, G; Giolo, JM; Lilla, S | 1 |
1 trial(s) available for dihydroergocristine and dihydroergocryptine
| Article | Year |
|---|---|
Identification and human pharmacokinetics of dihydroergotoxine metabolites in man: preliminary results.
Topics: Administration, Oral; Animals; Area Under Curve; Cattle; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dihydroergocornine; Dihydroergocristine; Dihydroergocryptine; Ergoloid Mesylates; Half-Life; Humans; Liver; Male; Microsomes, Liver; Middle Aged; Molecular Structure; Molecular Weight; Rats; Tablets; Tandem Mass Spectrometry; Vasodilator Agents | 2008 |
3 other study(ies) available for dihydroergocristine and dihydroergocryptine
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |
The prophylactic use of combined hydrogenated ergot alkaloids, dihydroergocornine, dihydroergocristine and dihydroergokryptine in migraine.
Topics: Cardiovascular Agents; Dihydroergocornine; Dihydroergocristine; Dihydroergocryptine; Dihydroergotoxine; Ergot Alkaloids; Migraine Disorders; Oxytocics; Safe Sex | 1955 |